Analog Devices CEO Vincent Roche sells 10,000 shares

Q: How many ADI shares did Vincent Roche sell, and at what price?

Vincent Roche, Analog Devices Inc.'s Chair & CEO, sold 10,000 shares at $396.94 per share on October 1, 2026. The sale was pursuant to a Rule 10b5-1 plan adopted December 3, 2025. On the same date, he exercised options covering 10,000 shares at $108.08 per share.

Q: How many shares were held in Vincent Roche's grantor trusts?

As of October 1, 2026, the reported holdings included 23,515 shares in the Vincent Roche 2024 Grantor Retained Annuity Trust and 50,000 shares in the Vincent Roche 2026 Grantor Retained Annuity Trust.

The sale followed a Rule 10b5-1 plan adopted December 3, 2025; Roche's reported option position after exercise was 50,803 shares.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Analog Devices Inc. Chair & CEO Vincent Roche exercised options covering 10,000 shares at $108.08 per share on October 1, 2026, acquiring 10,000 common shares, and sold 10,000 shares at $396.94 per share. The sale was pursuant to a Rule 10b5-1 plan adopted December 3, 2025. His reported option position after the exercise was 50,803 shares; the exercised option was fully vested and had an expiration date of March 13, 2029.

Insider Trade Summary 10b5-1

Exercise and Sale: 10,000 shares ($2.89M approx. pre-tax spread)

Exercise and Sale 5 txns

Insider ROCHE VINCENT

Role Chair & CEO

Sold 10,000 shs ($3.97M)

Approx. gross sale proceeds $3.97M

Approx. exercise cost $1.08M

Approx. pre-tax spread $2.89M

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Stock Option (right to buy) ^F4	10,000	$108.08	$1.08M
Exercise	Comm Stock - $.16-2/3 value	10,000	$108.08	$1.08M
Sale	Comm Stock - $.16-2/3 value ^F1	10,000	$396.94	$3.97M
holding	Comm Stock-$.16-2/3 value ^F2	--	--	--
holding	Comm Stock-$.16-2/3 value ^F3	--	--	--

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 50,803 contracts (Direct); Comm Stock - $.16-2/3 value — 115,460.083 shares (Direct); Comm Stock-$.16-2/3 value — 23,515 shares (Indirect, Vincent Roche 2024 Grantor Retained Annuity Trust); Comm Stock-$.16-2/3 value — 50,000 shares (Indirect, Vincent Roche 2026 Grantor Retained Annuity Trust)

Footnotes (4)

F1. These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person on December 3, 2025.
F2. Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024.
F3. Shares held by the Vincent Roche 2026 Grantor Retained Annuity Trust dated January 11, 2026.
F4. This option is fully vested.

Key Figures

Shares acquired through option exercise: 10,000 shares Option exercise price: $108.08 per share Shares sold: 10,000 shares +4 more

7 metrics

Shares acquired through option exercise 10,000 shares October 1, 2026

Option exercise price $108.08 per share October 1, 2026 exercise

Shares sold 10,000 shares October 1, 2026

Sale price $396.94 per share October 1, 2026 sale

Option shares after exercise 50,803 shares Reported after the October 1, 2026 exercise

2024 grantor trust shares 23,515 shares Held by the Vincent Roche 2024 Grantor Retained Annuity Trust as of October 1, 2026

2026 grantor trust shares 50,000 shares Held by the Vincent Roche 2026 Grantor Retained Annuity Trust as of October 1, 2026

Key Terms

Non-Qualified Stock Option, 10b5-1 plan, Grantor Retained Annuity Trust

3 terms

Non-Qualified Stock Option financial

"Non-Qualified Stock Option (right to buy)"

A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.

10b5-1 plan financial

"sold pursuant to a 10b5-1 plan adopted"

A 10b5-1 plan is a pre-arranged strategy that allows company insiders to buy or sell their shares at predetermined times and prices, even while they are aware of confidential information. It acts like a scheduled appointment for trading, helping ensure transactions happen transparently and legally, which can reassure investors that trades are not based on insider knowledge.

Grantor Retained Annuity Trust financial

"Vincent Roche 2024 Grantor Retained Annuity Trust"

A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ADI shares did Vincent Roche sell, and at what price?

Vincent Roche, Analog Devices Inc.'s Chair & CEO, sold 10,000 shares at $396.94 per share on October 1, 2026. The sale was pursuant to a Rule 10b5-1 plan adopted December 3, 2025. On the same date, he exercised options covering 10,000 shares at $108.08 per share.

How many ADI option shares did Vincent Roche have after exercising options?

His reported option position after the October 1, 2026 exercise was 50,803 shares. The exercised option was fully vested and had an expiration date of March 13, 2029.

How many shares were held in Vincent Roche's grantor trusts?

As of October 1, 2026, the reported holdings included 23,515 shares in the Vincent Roche 2024 Grantor Retained Annuity Trust and 50,000 shares in the Vincent Roche 2026 Grantor Retained Annuity Trust.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/05/2026 - 04:25 PM Accepted by SEC EDGAR 10/05/2026 - 04:25 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROCHE VINCENT

(Last)

(First)

(Middle)

ONE ANALOG WAY

(Street)

WILMINGTON

MASSACHUSETTS

01887

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ANALOG DEVICES INC [ ADI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chair & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Comm Stock - $.16-2/3 value	10/01/2026		M		10,000	A	$108.08	125,460.083	D
Comm Stock - $.16-2/3 value	10/01/2026		S		10,000⁽¹⁾	D	$396.94	115,460.083	D
Comm Stock-$.16-2/3 value								23,515	I⁽²⁾	Vincent Roche 2024 Grantor Retained Annuity Trust
Comm Stock-$.16-2/3 value								50,000	I⁽³⁾	Vincent Roche 2026 Grantor Retained Annuity Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Non-Qualified Stock Option (right to buy)	$108.08	10/01/2026		M			10,000	⁽⁴⁾	03/13/2029	Comm Stock - $.16-2/3 value	10,000	$108.08	50,803	D

Explanation of Responses:

1. These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person on December 3, 2025.

2. Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024.

3. Shares held by the Vincent Roche 2026 Grantor Retained Annuity Trust dated January 11, 2026.

4. This option is fully vested.

Remarks:

	/s/ Shelly Shaw, General Counsel, by Power of Attorney	10/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR